Yüklüyor......
Effect of desipramine on patients with breathing disorders in RETT syndrome
OBJECTIVE: Rett Syndrome (RTT) is a severe neurodevelopmental condition with breathing disorders, affecting around one in 10,000 female births. Desipramine, a noradrenaline reuptake inhibitor, reduced the number of apneas in Mecp2‐deficient mice, a model of RTT. We planned a phase 2 trial to test it...
Kaydedildi:
| Yayımlandı: | Ann Clin Transl Neurol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817841/ https://ncbi.nlm.nih.gov/pubmed/29468173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.468 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|